PHSI Designs MAC Pricing Benefiting HMO and Retail Pharmacy
| Industry | Managed Care/ PBM |
| Problem | A Medicaid HMO wanted to ensure that their Maximum Allowable Cost (MAC) list was controlling generic expenditures while providing a reasonable profit to their retail pharmacy networks. |
| PHSI Solution | PHSI created a unique model to analyze the costs associated with generic drugs in order to create competitive MAC lists incorporating the needs of all market segments. The MAC list aligned incentives for all stakeholders to promote generic substitution. |
| Results | The Medicaid HMO aligned financial incentives while increasing their generic substitution rate and lowering network complaints on generic pricing. |
Poll Results
August 2020 Question of the Month
Would you be willing to participate in a Phase 3 trial of a potential Covid-19 vaccine?
Yes: 71%
No: 29%
July 2020 Question of the Month
COVID-19 testing by community pharmacists will likely help pave the way for pharmacy provider status under Medicare, what is the expected time-frame?
1 year: 0%
2 years: 75%
3 years: 0%
4 years or more: 25%
Never: 0%
June 2020 Question of the Month
What percent of drug manufacturers will increase production of drug products in the US?
0%: 0%
1-10%: 14%
11-20%: 43%
21-30%: 29%
More than 30%: 14%
Contact
968 Perry Highway
Pittsburgh, PA 15237
Get Directions »
Phone: (412) 635-4650
Follow/Subscribe:
